$CYCU

Cycurion Announces Reverse Stock Split to Maintain Nasdaq Listing

Cycurion (CYCU) completed a 1-for-8 reverse stock split, reducing shares from 25.8M to 3.23M, effective August 28, 2026. The move aims to meet Nasdaq's minimum bid price requirements, with trading continuing under the same ticker.

Original reporting
Published Aug 29, 2026, 2:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 30, 2026, 6:17 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cycurion Announces Reverse Stock Split to Maintain Nasdaq Listing — source image
Decision brief

The 30-second read

$CYCUNeutralMed
01

Why it matters

The split aims to keep the listing, but may not change fundamentals.

02

Market read

Corporate action primarily relevant to current shareholders and short‑term traders.

03

What to watch

Potential cash‑in‑lieu for fractional shares and adjustments to equity awards could affect dilution.

Relevance 5/10Novelty 6/10Timing: effective Aug 28 2026

Background

Cycurion is a Nasdaq‑listed micro‑cap facing minimum bid price compliance issues.

Company-level read

Ticker impact

$CYCUNeutralHigh confidence
Context

Cycurion announced a 1‑for‑8 reverse stock split to maintain Nasdaq listing, effective Aug 28 2026.

Expected impact

modest upward pressure as share price adjusts to new share count

Evidence & confidence

Corporate action is clear and first reported; market typically reacts modestly to reverse splits.

Market effects

Minimal; reverse split does not affect sector fundamentals.

Limited to Cycurion shareholders; no broader regional effect.

Low; micro‑cap corporate action with no systemic impact.

Counterpoint

Reverse splits can signal underlying weakness; price may not sustain post‑split.

Key entities

  • Cycurion, Inc.

    Issuer of the reverse split.

Related articles

$CYCUHigh

Cycurion shares surge 37% more after $54.6M health IT contract win

Cycurion Inc. (CYCU) shares rose 37% in premarket trading after securing a $54.6M, 10-year contract for health IT modernization, adding to a 496% gain the prior day. The deal is expected to generate over $5M in annual revenue starting November 2026. The company reported a narrowed net loss and improved gross margins in Q1 2026. Analysts maintain a Buy rating with a $7.00 price target. Cycurion also faces a Nasdaq delisting threat for failing to meet the minimum bid price requirement, with a hear

$CYCUHigh

1 as margins hit 29.1%, HHS award signed – Minichart

Cycurion (NASDAQ: CYCU) announced a 1-for-8 reverse stock split to meet NASDAQ requirements. The company reported a gross margin increase to 29.1% and a $54.6M 10-year HHS contract. It also authorized a $500K share repurchase program and aims for profitability by Q2 2027. CEO Kevin Kelly addressed market manipulation allegations.